@WHO: "The 2⃣ is bilateral technology transfer, through voluntary licensing from a company that owns the patents on a #COVID19 vaccine to another company that can produce them, as AstraZeneca has done with SKBio in 🇰🇷 & the Serum Institute of 🇮🇳"-@DrTedros #VaccinEquity #Aid4Trade

@WHO: "The 2⃣ is bilateral technology transfer, through voluntary licensing from a company that owns the patents on a #COVID19 vaccine to another company that can produce them, as AstraZeneca has done with SKBio in 🇰🇷 & the Serum Institute of 🇮🇳"-@DrTedros #VaccinEquity #Aid4Trade

http://twitter.com/WHO
via IFTTT

Comments